Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2025-12-26 @ 3:26 AM
NCT ID:
NCT04714320
Pre Assignment Details:
Participants with uncontrolled hypertension who were on ≥ 3 antihypertensive medications were enrolled and randomized to receive either ISIS 757456 80 mg, ISIS 757456 120 mg or ISIS 757456 matched placebo for a 12-week treatment period.
Recruitment Details:
Participants took part in the study at investigative sites in the US and Canada from 28 April 2021 to 03 October 2022.
Study:
NCT04714320
Study Brief:
Results Section:
NCT04714320